⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PROK News
ProKidney Corp. Class A Ordinary Shares
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
globenewswire.com
PROK
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
globenewswire.com
PROK
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
globenewswire.com
PROK